Ligand Pharm (LGND)
$123.34 1.06 (0.87%)
18:07 EST LGND Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 2.63B
PE Ratio 57.64
Volume (Avg. Vol.) 310,400
Day's Range 121.00 - 126.00
52-Week Range 57.24 - 127.80
Dividend & Yield N/A (N/A)
LGND Stock Predictions, Articles, and Ligand Pharm News
- From InvestorPlace
- From the Web
It’s a good time to separate the weak from the strong.
The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
Insider buying could be a great bullish indicator for a stock. Insiders sell for many reason, but they only buy for one -- and maybe you should buy too.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
Here are some triple-a stocks to buy that are primed to start the new year going strong.
After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after dec....
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
Bitcoin may look attractive, but there are stocks to buy with growth potential that you don't have to worry about going broke to own.
Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.
The biotech industry has posted a turnaround in the first half of the year, despite facing pricing issues in 2016.
Here's a look at 4 drug stocks to buy preferred by analysts who have a deep knowledge and understanding of the industry and its companies.
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
The following stocks were moving the Manufacturing sector today.
From Talk Markets
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fulgent Genetics Inc (FLGT), where a total of 7,997 contracts have traded so far, representing approximately 799,700 underlying shares. That amounts to about 44.4% of FLGT's average daily trading volume over the past month of 1.8 million shares..
A study of analyst recommendations at the major brokerages shows that Ligand Pharmaceuticals Inc (LGND) is the #57 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period..
Navellier RatingsPowered by Portfolio Grader